Associated Papers
Nilotinib in KIT-driven advanced melanoma: Results from the phase II single-arm NICAM trial.
Larkin J et al.
Cell Reports. Medicine, 2024
KIT amplification and gene mutations in acral/mucosal melanoma in Korea.
Yun J et al.
Apmis : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica, 2011
Select a paper to view details